Transgene
Designs and develops viral-based immunotherapies.
Launch date
Employees
Market cap
$152m
Enterprise valuation
$136m (Public information from Sep 2024)
Share price
€1.022 TNG.PA
Illkirch Grand Est (HQ)
Authorizing premium user...